Victoria Catterson

Affiliations

BioSymetrics, Inc, New York, New York, USA.

Publications (1)

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.

Thorax

Avec: Zelalem Temesgen , Colleen F Kelley , Frank Cerasoli , Adrian Kilcoyne , Dale Chappell , Cameron Durrant , Omar Ahmed , Gabrielle Chappell , Victoria Catterson , Christopher Polk , Andrew Badley , Vincent C Marconi , Auteur inconnu

Réseau de co-auteurs

Zelalem Temesgen 1 collaboration

Colleen F Kelley 1 collaboration

Frank Cerasoli 1 collaboration

Adrian Kilcoyne 1 collaboration

Dale Chappell 1 collaboration

Cameron Durrant 1 collaboration

Omar Ahmed 1 collaboration

Gabrielle Chappell 1 collaboration

Christopher Polk 1 collaboration

Andrew Badley 1 collaboration

Vincent C Marconi 1 collaboration

None None 1 collaboration